304 related articles for article (PubMed ID: 29743053)
1. PDXliver: a database of liver cancer patient derived xenograft mouse models.
He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
[TBL] [Abstract][Full Text] [Related]
2. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.
Brown KM; Xue A; Julovi SM; Gill AJ; Pavlakis N; Samra JS; Smith RC; Hugh TJ
J Surg Res; 2018 Jul; 227():158-167. PubMed ID: 29804848
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
5. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
6. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
[No Abstract] [Full Text] [Related]
7. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
[TBL] [Abstract][Full Text] [Related]
8. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
10. Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
Swick AD; Stein AP; McCulloch TM; Hartig GK; Ong IM; Sampene E; Prabakaran PJ; Liu CZ; Kimple RJ
Oral Oncol; 2017 Jan; 64():65-72. PubMed ID: 28024726
[TBL] [Abstract][Full Text] [Related]
11. Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
Blomme A; Van Simaeys G; Doumont G; Costanza B; Bellier J; Otaka Y; Sherer F; Lovinfosse P; Boutry S; Palacios AP; De Pauw E; Hirano T; Yokobori T; Hustinx R; Bellahcène A; Delvenne P; Detry O; Goldman S; Nishiyama M; Castronovo V; Turtoi A
Oncogene; 2018 Mar; 37(9):1237-1250. PubMed ID: 29242606
[TBL] [Abstract][Full Text] [Related]
12. Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization.
Zou J; Liu Y; Wang J; Liu Z; Lu Z; Chen Z; Li Z; Dong B; Huang W; Li Y; Gao J; Shen L
J Transl Med; 2018 Jan; 16(1):15. PubMed ID: 29370817
[TBL] [Abstract][Full Text] [Related]
13. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
Gandara DR; Mack PC; Bult C; Li T; Lara PN; Riess JW; Astrow SH; Gandour-Edwards R; Cooke DT; Yoneda KY; Moore EH; Pan CX; Burich RA; David EA; Keck JG; Airhart S; Goodwin N; de Vere White RW; Liu ET
Clin Lung Cancer; 2015 May; 16(3):165-72. PubMed ID: 25838158
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development.
Gu Q; Zhang B; Sun H; Xu Q; Tan Y; Wang G; Luo Q; Xu W; Yang S; Li J; Fu J; Chen L; Yuan S; Liang G; Ji Q; Chen SH; Chan CC; Zhou W; Xu X; Wang H; Fang DD
Oncotarget; 2015 Aug; 6(24):20160-76. PubMed ID: 26062443
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
[TBL] [Abstract][Full Text] [Related]
16. Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
Wang Y; Wang JX; Xue H; Lin D; Dong X; Gout PW; Gao X; Pang J
Differentiation; 2016; 91(4-5):15-9. PubMed ID: 26547391
[TBL] [Abstract][Full Text] [Related]
17. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
[TBL] [Abstract][Full Text] [Related]
18. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
[TBL] [Abstract][Full Text] [Related]
20. PDX Finder: A portal for patient-derived tumor xenograft model discovery.
Conte N; Mason JC; Halmagyi C; Neuhauser S; Mosaku A; Yordanova G; Chatzipli A; Begley DA; Krupke DM; Parkinson H; Meehan TF; Bult CC
Nucleic Acids Res; 2019 Jan; 47(D1):D1073-D1079. PubMed ID: 30535239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
